DOCSLIB.ORG

British Journal of Urology International

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
British Journal of Urology International BJU International Official journal of the British Association of Urological Surgeons and the Urological Society of Australasia August 2005 - Vol. 96 Issue 3 Page i-469 i Editor's comment Online publication date: 24-Jul-2005 Comments 231 How should we advise patients about the chemoprevention of prostate cancer? Roger S. Kirby, John M. Fitzpatrick Online publication date: 24-Jul-2005 232 A proposal for a new classification for operative procedures for stress urinary incontinence Paul Abrams, Paul Hilton, Malcolm Lucas, Tony Smith Online publication date: 24-Jul-2005 233 Renal transplantation and manpower issues Dler Besarani, David Cranston Online publication date: 24-Jul-2005 234 Is premature ejaculation all in the mind? John Dean, Ian Eardley, Geoff Hackett, Jeremy Heaton, Roger Kirby Online publication date: 24-Jul-2005 Mini-reviews 237 Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia Ajay Nehra Online publication date: 24-Jul-2005 244 Robotic renal and adrenal surgery: present and future Rajeev Kumar, Ashok K. Hemal, Mani Menon Online publication date: 24-Jul-2005 250 Targeting bladder outlet obstruction from benign prostatic enlargement via the nitric oxide/cGMP pathway? André Reitz, Michael Müntener, Axel Haferkamp, Markus Hohenfellner, Brigitte Schurch Online publication date: 24-Jul-2005 254 The vital role of creativity in academic departments Jeremy P.W. Heaton Online publication date: 24-Jul-2005 Great Drug Classes 257 Phosphodiesterase type 5 inhibitors for erectile dysfunction Culley C. Carson, Tom F. Lue Online publication date: 24-Jul-2005 Urological Oncology 281 Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma John T. Leppert, John S. Lam, Allan J. Pantuck, Robert A. Figlin, Arie S. Belldegrun Online publication date: 24-Jul-2005 286 Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development Brian I. Rini, Jeffrey A. Sosman, Robert J. Motzer Online publication date: 24-Jul-2005 291 Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review Nathan Lawrentschuk, Johan Gani, Richard Riordan, Steven Esler, Damien M. Bolton Online publication date: 24-Jul-2005 296 Epothilones and the next generation of phase III trials for prostate cancer Manish S. Bhandari, Maha Hussain Online publication date: 24-Jul-2005 303 Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of <10 ng/mL Alison J. Birtle, Alex Freeman, John R.W. Masters, Heather A. Payne, Stephen J. Harland, contributors to the BAUS Section of Oncology Cancer Registry Online publication date: 24-Jul-2005 308 Age-specific reference levels of serum prostate- specific antigen and prostate volume in healthy Arab men Elijah O. Kehinde, Olusegun A. Mojiminiyi, Mehraj Sheikh, Kaleel A. Al-Awadi, Abdallah S. Daar, Adel Al-Hunayan, Jehoram T. Anim, Aisha A. Al-Sumait Online publication date: 24-Jul-2005 313 Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy John T. Stoffel, Linda Topjian, John A. Libertino Online publication date: 24-Jul-2005 316 New perioperative management reduces bleeding in radical retropubic prostatectomy Martin Schostak, Klaudia Matischak, Markus Müller, Michel Schäfer, Mark Schrader, Frank Christoph, Kurt Miller Online publication date: 24-Jul-2005 320 Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer? Jonathan I. Izawa, Iliana Lega, Donal Downey, Joseph L. Chin, Patrick P. Luke Online publication date: 24-Jul-2005 324 Increasing the number of biopsy cores improves the concordance of biopsy Gleason score to prostatectomy Gleason score Christopher L. Coogan, Kalyan C. Latchamsetty, Jason Greenfield, John M. Corman, Barlow Lynch, Christopher R. Porter Online publication date: 24-Jul-2005 328 Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancer Steven Lehrer, Edward J. Diamond, Nelson N. Stone, Richard G. Stock Online publication date: 24-Jul-2005 330 Inguinal hernia repair with polypropylene mesh during radical retropubic prostatectomy: an easy and practical approach Alberto Azoubel Antunes, Marcos Dall'oglio, Alexandre Crippa, Miguel Srougi Online publication date: 24-Jul-2005 334 An office-based immunodiagnostic assay for detecting urinary nuclear matrix protein 52 in patients with bladder cancer Abdelfattah M. Attallah, Hanem A. Sakr, Hisham Ismail, El-Sayed K. Abdel-Hady, Ibrahim El-Dosoky Online publication date: 24-Jul-2005 Lower Urinary Tract 341 Detrusor myectomy: long-term results with a minimum follow-up of 2 years Sunil P.V. Kumar, Paul H. Abrams Online publication date: 24-Jul-2005 345 Are conventional pressure-flow measurements dependent upon filled volume? Kanagasabai Sahadevan, Ann S. Leonard, Robert S. Pickard Online publication date: 24-Jul-2005 350 Validation of a patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire Darren Clayson, Diane Wild, Helen Doll, Karen Keating, Kathleen Gondek Online publication date: 24-Jul-2005 360 A novel midstream urine-collection device reduces contamination rates in urine cultures amongst women Simon R. Jackson, Mathew Dryden, Paul Gillett, Paddy Kearney, Rosemary Weatherall Online publication date: 24-Jul-2005 365 How do urinary diaries of women with an overactive bladder differ from those of asymptomatic controls? Mary P. Fitzgerald, Deborah Ayuste, Linda Brubaker Online publication date: 24-Jul-2005 368 A comparison of the effect of 1.5% glycine and 5% glucose irrigants on plasma serum physiology and the incidence of transurethral resection syndrome during prostate resection Justin W. Collins, Seamus MacDermott, Richard A. Bradbrook, Francis X. Keeley Jr, Anthony G. Timoney Online publication date: 24-Jul-2005 Sexual Medicine 373 The management of penile fracture based on clinical and magnetic resonance imaging findings Ahmad Abolyosr, Alaa E. Abdel Moneim, Atef M. Abdelatif, Medhat A. Abdalla, Hisham M.K. Imam Online publication date: 24-Jul-2005 Upper Urinary Tract 379 Outcome from percutaneous nephrolithotomy in patients with spinal cord injury, using a single- stage dilator for access Nathan Lawrentschuk, David Pan, Richard Grills, John Rogerson, David Angus, David R. Webb, Damien M. Bolton Online publication date: 24-Jul-2005 385 Multimodal management of urolithiasis in renal transplantation Ben Challacombe, Prokar Dasgupta, Richard Tiptaft, Jonathan Glass, Geoff Koffman, David Goldsmith, Mohammed S. Khan Online publication date: 24-Jul-2005 Reconstructive Urology 391 Asymptomatic bacteriuria in men with orthotopic ileal neobladders: possible relationship to nocturnal enuresis Mohamed Abdel-Latif, Ahmed Mosbah, Magdy S. El Bahnasawy, Essam Elsawy, Atallah A. Shaaban Online publication date: 24-Jul-2005 Paediatric Urology 397 Vesicostomy revisited: the best treatment for the hostile bladder in myelodysplastic children? Shelby N. Morrisroe, R. Corey O'Connor, Dana K. Nanigian, Eric A. Kurzrock, Anthony R. Stone Online publication date: 24-Jul-2005 401 Inguinal hernia in female infants: a cue to check the sex chromosomes? Asma Deeb, Ieuan A. Hughes Online publication date: 24-Jul-2005 404 Nocturnal enuresis at 7.5 years old: prevalence and analysis of clinical signs Richard J. Butler, Jean Golding, Kate Northstone, The ALSPAC Study Team Online publication date: 24-Jul-2005 411 Efficacy of tolterodine as a first-line treatment for non-neurogenic voiding dysfunction in children Semih Ayan, Kemal Kaya, Kahraman Topsakal, Hakan Kilicarslan, Gokhan Gokce, Yener Gultekin Online publication date: 24-Jul-2005 Investigative Urology 416 The src-family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt George J. Chiang, Brian R. Billmeyer, David Canes, John Stoffel, Alireza Moinzadeh, Christina A. Austin, Monika Kosakowski, Kimberly M. Rieger-Christ, John A. Libertino, Ian C. Summerhayes Online publication date: 24-Jul-2005 423 Sildenafil inhibits the formation of superoxide and the expression of gp47phox NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells Anthony J. Koupparis, Jamie Y. Jeremy, Saima Muzaffar, Raj Persad, Nilima Shukla Online publication date: 24-Jul-2005 428 Loss of ryanodine receptor calcium-release channel expression associated with overactive urinary bladder smooth muscle contractions in a detrusor instability model Hai-Hong Jiang, Bo Song, Gen-Sheng Lu, Qian-Jun Wen, Xi-Yu Jin Online publication date: 24-Jul-2005 Pharmaceutical review 435 Unseen forces at AUA 2005? Michael G. Wyllie Online publication date: 24-Jul-2005 Points of Technique 437 A simple modification to the Albarran deflector enhances endoscopic control Kevin R. Loughlin Online publication date: 24-Jul-2005 439 Cystoscopic removal of a JJ stent using a suture 'lasso' Govind V.S. Murthi, Peter Cuckow Online publication date: 24-Jul-2005 Letters 440 Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases Michele Gallucci, Roberta Merola, Costantino Leonardo, Enzo Maria Ruggeri, Anna Maria Cianciulli Online publication date:
Load more

Recommended publications
  • Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017
    Supplementary Online Content Berríos-Torres SI, Umscheid CA, Bratzler DW, et al; Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. Published online May 3, 2017. doi:10.1001/jamasurg.2017.0904 eAppendix 1. Centers for Disease Control and Prevention, Guideline for the Prevention of Surgical Site Infection 2017 –Background, Methods and Evidence Summaries eAppendix 2. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017: Supplemental Tables This supplementary material has been provided by the authors to give readers additional information about their work. © 2017 American Medical Association. All rights reserved. 1 Downloaded From: https://jamanetwork.com/ on 09/30/2021 eAppendix 1. Centers for Disease Control and Prevention, Guideline for the Prevention of Surgical Site Infection 2017: Background, Methods and Evidence Summaries TABLE OF CONTENTS 1. BACKGROUND ........................................................................................................................................................................................................................................................... 4 1.1. Prosthetic Joint Arthroplasty ................................................................................................................................................................................................................................
    [Show full text]
  • Appendix C Wound Dressings for Surgical Site Infection Prevention
    Surgical site infection Surgical site infection National Collaborating Centre for Women’s and Children’s Health Other NICE guidelines produced by the National Collaborating Centre for Women’s and Children’s Health include: • Antenatal care: routine care for the healthy pregnant woman • Fertility: assessment and treatment for people with fertility problems • Caesarean section • Type 1 diabetes: diagnosis and management of type 1 diabetes in children and young people • Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception • Urinary incontinence: the management of urinary incontinence in women • Heavy menstrual bleeding • Feverish illness in children: assessment and initial management in children younger than 5 years • Urinary tract infection in children: diagnosis, treatment and long-term management • Intrapartum care: care of healthy women and their babies during childbirth • Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years • Surgical management of otitis media with effusion in children • Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period Surgical site infection • Induction of labour Guidelines in production include: prevention and treatment of • Diarrhoea and vomiting in children under 5 prevention and treatment of • When to suspect child maltreatment • Hypertensive disorders in pregnancy • Neonatal jaundice surgical site infection • Constipation in children • Bacterial
    [Show full text]
  • The Canadian Medical Review
    v^I:J.l^aLiJaT^ rAmrca^ Rexyiew m vol r^^^^^^ INDEX, 1895. 528626 VOL. I. It. 10.51 ORIGINAL COMMUNICATIONS. PAGE Recent Electro Theiapeusis of Goitre, with Improvements in Apparatus. By Dr. C. R. Dickson, Toronto i Treatment of Colles' Fracture. By Dr. William Britton, Toronto 5 Tumor of the Middle Lobe of the Cerebellum. By D. C. Meyers, M.D., Toronto 35 Two Cases of Tubal Gestation. By A. B. Atherton, M.D., Toronto * 38 The Care of the Eyes in Newspaper Work. By Dr. G. S. Ryerson, Toronto 75 Regarding the Eruption in a Case of Variola, in which Vac- cinia Ran Concurrently ; with Remarks on the Pathology. By Dr. J. N. E. Brown, Toronto 77 The Treatment of Dysmenorrhoea. By Albert A. Macdonald, M.D 119 The Treatment of Diseases of the Fallopian Tubes. By Dr. A. Lapthorn Smith 159 The Treatment of Diseases of the Fallopian Tubes and Ovaries. By A. Lapthorn Smith, B.A., M. D., Montreal 199 Notes on the Medical Service. By Dr. G. Sterling Ryerson . 208 CLINICAL NOTES. A Case of Infantile Spinal Paralysis. By Dr. W. W. Bremner, Toronto 8 A Peculiar Fracture of the Clavicle. By Dr. J. J. Cassidy, Toronto 10 A Case of Malingering. By Murray McFarlane, M.D., Toronto 41 Short Notes on Three Cases of Poisoning. By Dr. B. Spencer, Toronto 82 Hysteria in a Child. By Dr. D. C Meyers, Toronto 83 Notes on a Case of Arrested Tuberculosis. By Dr. Garratt, Toronto 85 A Peculiar Case of Diphtheria. By Dr. J. T. Fotheringham, Toronto 86 Foreign Body in CEsophagus.
    [Show full text]
  • Oesophageal Foreign Bodies - from Diagnostic Challenge to Therapeutic Dilemma
    General Report Chirurgia (2016) 111: 102-114 No. 2, March - April Copyright© Celsius Oesophageal Foreign Bodies - from Diagnostic Challenge to Therapeutic Dilemma Dragoæ Predescu1, Irina Predescu2, Codruå Sarafoleanu2, Silviu Constantinoiu1 1Esophageal and General Surgery Clinic, St. Mary Hospital, Carol Davila University of Medicine and Pharmacy Bucharest, Romania 2ENT Department, St. Mary Hospital, Carol Davila University of Medicine and Pharmacy Bucharest, Romania Rezumat Manifestãrile de alertã, care indicã apariåia complicaåiilor sunt: stare febrilã, alterarea stãrii generale, durere (proiecåie verebralã Corpii strãini esofagieni - de la provocare diagnosticã la /interscapularã), împãstare, emfizem cervical subcutanat. dilemã terapeuticã Diagnosticul imagistic prin variantele sale (Rx simplã, tranzit Ingestia de corpi strãini, frecvent întâlnitã în serviciile de baritat, CT, RMN) rãmâne veriga esenåialã în identificarea urgenåã, rãmâne o provocare pentru medici în ciuda mãsurilor lezionalã æi decizia terapeuticã. Evaluarea endoscopicã (rigidã preventive æi a progreselor tehnice datoritã frecvenåei æi sau flexibilã) este obligatorie, permiåând æi gesturi terapeutice. complicaåiilor posibile, complicaåii grave ce pot întuneca Evolutiv (80-90%) FB migreazã în stomac fiind eliminaåi pe cãi prognosticul vital sau pot fi sursã de morbiditate la distanåã. naturale, la cca 10-20% este necesarã extracåie pe cale endos- Experienåa clinicii ”Sf. Maria” raporteazã în intervalul 2000- copicã æi doar la 1% din cazuri se impune un gest chirurgical. 2015, 39 de pacienåi diagnosticaåi cu ingestie de FB, din care Tratamentul cazurilor necomplicate este esenåial endoscopic 26 fixaåi la nivelul esofagului iar restul de 13 au trecut în aval fie, de excepåie, intervenåie chirurgicalã pentru extragerea spontan (5 recuperaåi din stomac, 6 evacuaåi natural, 2 cazuri cu corpului strãin. În faåa complicaåiilor, chirurgia este singura perforaåie colicã).
    [Show full text]
  • Clinical Presentation and Diagnosis of Acute Postoperative Spinal Implant Infection (PSII)
    771 Review Article on Postoperative Spinal Implant Infection Clinical presentation and diagnosis of acute postoperative spinal implant infection (PSII) Timo Zippelius1, Justus Bürger2, Friederike Schömig2, Michael Putzier2, Georg Matziolis1, Patrick Strube1 1Orthopaedic Professorship of the University Hospital Jena, Orthopaedic Department of the Waldkliniken Eisenberg, Eisenberg, Germany; 2Center for Musculoskeletal Surgery, Charité University Medicine Berlin, Berlin, Germany Contributions: (I) Conception and design: T Zippelius, G Matziolis, P Strube; (II) Administrative support: G Matziolis, J Bürger; (III) Provision of study material or patients: None; (IV) Collection and assembly of data: F Schömig, J Bürger; (V) Data analysis and interpretation: F Schömig, J Bürger; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Dr. med. Timo Zippelius. Orthopaedic Department of the Waldkliniken Eisenberg, Orthopaedic Professorship of the University Hospital Jena, Klosterlausnitzer Str. 81, 07607 Eisenberg, Germany. Email: [email protected]. Abstract: Acute postoperative infections after surgical interventions on the spinal column are associated with prolonged treatment duration, poor patient outcomes, and a high socioeconomic burden. In the field of joint replacement, guidelines have been established with recommendations for the diagnosis and treatment of such complications, but in spinal surgery there are no definitions permitting distinction between early and late infections and no specific instructions for their management. Various factors increase the risk of acute postoperative infection, including blood transfusions, leakage of cerebrospinal fluid, urinary tract infection, injury of the dura mater, an American Society of Anesthesiologists (ASA) score >2, obesity, diabetes mellitus, and surgical revision. We suggest defining all infections occurring within the first 4 weeks after spinal surgery as early infections.
    [Show full text]
  • Phh 1333 01 Vivano
    02/2016 Vivano® Spectrum Convincing case examples of negative-pressure wound therapy. Abdominal · Traumatic · Chronic · Special Indication Editorial details Published by PAUL HARTMANN AG, P. O. Box 1420, 89504 Heidenheim, Telephone: +49 7321 36 – 0, www.hartmann.info Issue: 02/2016 Photographs: Martin Huťan (p. 7), Cristian Velicescu (p. 9), Adam Bobkiewicz (p. 11), Jiří Voves (p. 13), Zs Szentkereszty (p. 15), Astrid Schielke (p. 17), Wim Fleischmann (p. 19), Miroslav Budoš (p. 21), Susanu Sidonia (p. 23), Csaba Tóth (p.25), Sándor Pellek (p. 27), Stefan Georgescu (p. 29), Natália Santos (p. 31), Thorsten Vowinkel (p. 33), Darko Jurišić (p. 35), Martin Bohac (p. 37), Tomasz Tuzikiewicz (p. 39), Michal Konrád (p. 41), Marco Fraccalvieri (p. 43), Berthold Johann Vogel (p. 45), Title: © Formzwei, Stuttgart Copyright: PAUL HARTMANN AG reserves all rights, such as reprints, also of images, reproductions of any kind, talks, radio, audio and television broadcasts as well as the storage in data processing systems, including excerpts or translations. The cases in this journal are shown as they have been seen in clinical practice and independently conducted by the responsible health care professionals within their freedom of treatment and in certain cases using the products off-label. They have not been edited by PAUL HARTMANN AG and do not represent clinical recommendations of PAUL HARTMANN AG. The only officially approved use of the products from the VIVANO range recommended by PAUL HARTMANN AG can be found in the respective instructions for use. Editorial Dear Colleagues, I am very pleased to introduce the sixth edition of the “Vivano Spectrum” series.
    [Show full text]
  • Necrotising Enterocolitis in Preterm Infants With
    JURNALUL PEDIATRULUI – Year XVII, Vol. XVII, Nr. 65-66, january-junre 2014 EDITOR IN CHIEF Eugen Sorin BOIA CO-EDITORS Radu Emil IACOB Liviu POP Maria TRAILESCU SECRETARY Radu Emil IACOB Vlad Laurentiu DAVID EDITORIAL BOARD O Adam Valerica Belengeanu Marioara Boia A Craciun M Gafencu Daniela Iacob A Pirvan CM Popoiu Maria Puiu R Spataru I Velea EDITORIAL CONSULTANTS M Ardelean – Salzburg, Austria Valerica Belengeanu – Timisoara, Romania Jana Bernic – Chisinau, Moldavia ES Boia – Timisoara, Romania Maria Bortun – Timisoara, Romania V Fluture – Timisoara, Romania S Garofallo – Milano, Italy DG Gotia – Iasi, Romania ADDRESS C Ilie – Timisoara, Romania Tamás Kovács – Szeged, Hungary Timisoara, Romania Silvo Lipovšek– Maribor, Slovenia Gospodarilor Street, nr. 42 E Lazăr – Timisoara, Romania Tel: +4-0256-439441 J Mayr – Basel, Switzerland cod 300778 Eva Nemes – Craiova, Romania e-mail: [email protected] Gloria Pelizzo – Pavia, Italy L Pop – Timisoara, Romania JURNALUL PEDIATRULUI – Year XVII, I Popa – Timisoara, Romania Maria Puiu – Timisoara, Romania Vol. XVII, Nr. 65-66, january-june 2014 GC Rogers – Greenville, USA www.jurnalulpediatrului.ro J Schalamon – Graz, Austria ISSN 2065 – 4855 I Simedrea – Timisoara, Romania Rodica Stackievicz – Kfar Sava, Israel REVISTA SOCIETĂŢII ROMÂNE H Stackievicz – Hadera, Israel DE CHIRURGIE PEDIATRICĂ Penka Stefanova - Plvdiv, Bulgaria www.srcp.ro C Tica – Constanta, Romania 1 JURNALUL PEDIATRULUI – Year XVII, Vol. XVII, Nr. 65-66, january-junre 2014 CONTENTS 1. A SEVEN YEARS EXPERIENCE IN HIRSCHSPRUNG’S DISEASE TREATMENT Radu-Iulian Spataru, Niculina Bratu, Monica Ivanov, Dan-Alexandru Iozsa………………………………………………3 2. DAILY PRACTICE OF MECHANICAL VENTILATION IN A PEDIATRIC INTENSIVE CARE UNIT - EXPERIENCE OF THE FIRST PEDIATRIC CLINIC TIMISOARA Daniela Chiru, Craciun A, Tepeneu NF, David VL, Otilia Marginean, Ilie C.…………………………………….....…….6 3.
    [Show full text]
  • Infections of the Musculoskeletal System”
    Infections of the musculoskeletal system Basic principles, prevention, diagnosis and treatment Published by the swiss orthopaedics and the Swiss Society for Infectious Diseases expert group “Infections of the musculoskeletal system” 1st electronic edition in English 2016 Peter E. Ochsner, Olivier Borens, Paul-Michael Bodler, Ivan Broger, Gerhard Eich, Fritz Hefti, Thomas Maurer, Hubert Nötzli, Stefan Seiler, Domizio Suvà, Andrej Trampuz, Ilker Uçkay, Markus Vogt, Werner Zimmerli Infections of the musculoskeletal system Basic principles, prevention, diagnosis and treatment 1st electronic edition in English 2016 Published by swiss orthopaedics and the Swiss Society for Infectious Diseases expert group “Infections of the musculoskeletal system” Cover illustrations: Femoral head prosthesis with delayed infection, resulting in cartilage wear, acetabular roof cysts and loosening of cement and prosthesis. Detail: Implant surface with established biofilm (scanning electron microscope). 1st German edition 2013, reprint 2014 2nd German edition 2015, reprint 2016 1st English edition 2014 1st French edition 2015 1st Chinese edition 2015 Important information about using this text: The reader can rest assured that the expert group, the authors, the editor and the publisher have taken great care when referring to dosages or recommended appli- cations within these guidelines to ensure that they conform to the state of the art. However, each user is advised to discuss medication dosages with qualified specialists and to verify them by carefully studying the corresponding package insert prior to initiating treatment. Any updates to treatment plans must also be taken into consideration. The expert group would like to encourage all users to report any inaccuracies. The contents of these guidelines are copyright protected.
    [Show full text]
  • Archive of Clinical Cases
    www.clinicalcases.eu Archive of Clinical Cases Subpectoral pacemaker implant after repeated pocket complications due to “senile pruritus” Andreea-Maria Ursaru1, Andreea-Mihaela Ignat*,1, Dana Corduneanu2, Gabriel Mazilu3, Antoniu Octavian Petriș1,4, Dan-Nicolae Tesloianu1 1Cardiology Department, “Sf. Spiridon” University Emergency Hospital, Iasi, Romania, 2Internal Medicine Department, “Sf. Spiridon” University Emergency Hospital, Iasi, Romania, 3Plastic and Reconstructive Microsurgery Department, “Sf. Spiridon” University Emergency Hospital, Iasi, Romania, 4“Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania Abstract Complications that can occur after pacemaker implant may be surgical or programming function related. We report a case of an 89-years old patient with slow atrial fibrillation, initially treated by external temporary pacing, and then by permanent pacemaker implant. The clinical course in the first months after procedure was uneventful, but after a half-year from the first admission, the patient addressed for pacemaker pocket infection, complaining of intense pruritus. After the drainage of the purulent secretions, the patient developed pocket hematoma, despite of Velpeau bandages and antipruritic drugs. Being a non-compliant patient with high risk of reinfection, it was decided, four days later after hematoma evacuation, to relocate the device on the same side, beneath pectoralis major muscle. This case presents two of the device pocket surgical complications (infection and hematoma) that occurred long after the implantation procedure due to senile pruritus. Keywords: pacemaker pocket infection, permanent pacemaker, senile pruritus, pocket hematoma, subpectoral pacemaker implant Introduction palpability, or exposure, plastic surgeons may be consulted for reimplanting the device using Originally implanted in the anterior a subpectoral approach [4].
    [Show full text]
  • Surgical Site Infection
    DRAFT FOR CONSULTATION Surgical site infection National Collaborating Centre for Women’s and Children’s Health Commissioned by the National Institute for Health and Clinical Excellence DRAFT FOR CONSULTATION April 2008 RCOG Press Surgical site infection: full guideline DRAFT (April 2008) page i of 165 DRAFT FOR CONSULTATION Contents Guideline Development Group membership and acknowledgements iv Guideline Development Group iv Acknowledgements iv Stakeholder organisations v Abbreviations ix Glossary of terms xi 1 Introduction 1 1.1 Surgical site infection 1 1.2 Aim of the guideline 4 1.3 Areas outside of the remit of the guideline 4 1.4 For whom is the guideline intended? 4 1.5 Who has developed the guideline? 5 1.6 Other relevant documents 5 1.7 Guideline methodology 5 1.8 Schedule for updating the guideline 9 2 Summary of recommendations and care pathway 10 2.1 Key priorities for implementation (key recommendations) 10 2.2 Summary of recommendations 11 2.3 Key priorities for research 14 2.4 Summary of research recommendations 15 2.5 Care pathway 16 3 Risk Factors 18 4 Information for patients 19 5 Preoperative phase 21 5.1 Preoperative showering 21 5.2 Hair removal 23 5.3 Patient theatre attire 26 5.4 Non-sterile theatre wear 26 5.5 Staff leaving the operating area in non-sterile theatre wear 27 5.6 Nasal decontamination 28 5.7 Mechanical bowel preparation 30 5.8 Hand decontamination (general) 32 5.9 Hand jewellery, artificial nails and nail polish 32 5.10 Antibiotic prophylaxis 33 6 Intraoperative phase 46 6.1 Hand decontamination (scrubbing)
    [Show full text]
  • Surgical Site Infection Surgical Site Infection National Collaborating Centre for Women’S and Children’S Health
    Surgical site infection Surgical site infection National Collaborating Centre for Women’s and Children’s Health Other NICE guidelines produced by the National Collaborating Centre for Women’s and Children’s Health include: • Antenatal care: routine care for the healthy pregnant woman • Fertility: assessment and treatment for people with fertility problems • Caesarean section • Type 1 diabetes: diagnosis and management of type 1 diabetes in children and young people • Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception • Urinary incontinence: the management of urinary incontinence in women • Heavy menstrual bleeding • Feverish illness in children: assessment and initial management in children younger than 5 years • Urinary tract infection in children: diagnosis, treatment and long-term management • Intrapartum care: care of healthy women and their babies during childbirth • Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years • Surgical management of otitis media with effusion in children • Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period Surgical site infection • Induction of labour Guidelines in production include: prevention and treatment of • Diarrhoea and vomiting in children under 5 prevention and treatment of • When to suspect child maltreatment • Hypertensive disorders in pregnancy • Neonatal jaundice surgical site infection • Constipation in children • Bacterial
    [Show full text]
  • Prevention of Surgical Site Infections
    Prevention of Surgical Site Infections Sinil Nair, CIC Infection Control Expert Clinical Quality and Healthcare Accreditation Department, MOHAP Background a) The second most common (20%) of all HAIs in hospitalized patients. b) Occurs in 2%–5% of patients undergoing inpatient surgery. c) One of the most preventable HAIs. a) Up to 60% of SSIs are preventable by using evidence-based guidelines. d) Each SSI is associated with ≈ 7–11 additional hospital-days. Background e) 3% Mortality f) Patients with an SSI have a 2–11-times higher risk of death compared with operative patients without an SSI. g) 77% of deaths in patients with SSI are directly attributable to SSI. h) The most costly HAI i) Long term disabilities Types of SSI NHSN Definitions 1. Superficial incisional SSI Must meet the following criteria: a) Infection occurs within 30 days after any operative procedure (where day 1 = the procedure date) AND a) involves only skin and subcutaneous tissue of the incision AND c) patient has at least one of the following: i. purulent drainage from the superficial incision. ii. organisms identified from an aseptically-obtained specimen from the superficial incision or subcutaneous tissue by a culture or non-culture based microbiologic testing method which is performed for purposes of clinical diagnosis or treatment (e.g., not Active Surveillance Culture). iii. superficial incision that is deliberately opened by a surgeon, attending physician or other designee and culture or non-culture based testing is not performed. AND patient has at least one of the following signs or symptoms: pain or tenderness; localized swelling; erythema; or heat.
    [Show full text]